Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study
出版年份 2015 全文链接
标题
Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study
作者
关键词
Children, Pharmacoepidemiology, ADHD, Psychostimulant treatment
出版物
BMC Pediatrics
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-09-11
DOI
10.1186/s12887-015-0435-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety of medicines used for ADHD in children: a review of published prospective clinical trials
- (2014) A. Clavenna et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009–2012: Focus on children, adolescents and prescriber specialty
- (2014) Emily A Karanges et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Period Prevalence of Concomitant Psychotropic Medication Usage Among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder During 2009
- (2014) Keith A. Betts et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010
- (2014) Holly E. Erskine et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
- (2014) Erik von Elm et al. International Journal of Surgery
- Five-Fold Increase in National Prevalence Rates of Attention-Deficit/Hyperactivity Disorder Medications for Children and Adolescents with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and other Psychiatric Disorders: A Danish Register-Based Study
- (2013) Søren Dalsgaard et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
- (2013) Vanja Sikirica et al. Drugs in research & development
- The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care
- (2012) Suzanne McCarthy et al. BMC Pediatrics
- Antibiotic prescribing trends in a paediatric sub-population in Ireland
- (2012) C Keogh et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Pharmacologic Treatment of Attention-Deficit/Hyperactivity Disorder in Children: Incidence, Prevalence, and Treatment Patterns in The Netherlands
- (2011) Paul Hodgkins et al. CLINICAL THERAPEUTICS
- European guidelines on managing adverse effects of medication for ADHD
- (2010) J. Graham et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Trends in Incidence and Characteristics of Children, Adolescents, and Adults Initiating Immediate- or Extended-Release Methylphenidate or Atomoxetine in The Netherlands During 2001–2006
- (2010) Els van den Ban et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- The distribution of GPs in Ireland in relation to deprivation
- (2010) Conor Teljeur et al. HEALTH & PLACE
- Changes in Use of Psychostimulant Medication for ADHD in South Australia (1990–2006)
- (2009) Brenton Prosser et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data
- (2009) Eric Acquaviva et al. BMC Psychiatry
- Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
- (2009) Sharon B. Wigal CNS DRUGS
- Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
- (2009) Stephen V. Faraone et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- The NICE ADHD health technology assessment: A review and critique
- (2008) Michael Schlander Child and Adolescent Psychiatry and Mental Health
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started